NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?
1 other identifier
observational
35
1 country
1
Brief Summary
Neonates and infants that have cardiac surgery with cardiopulmonary bypass (CPB) for congenital heart disease are at great risk for experiencing life-threatening low cardiac output syndrome (LCOS) in the first 24 hours after surgery. The poor perfusion and inadequate oxygen delivery that occurs may result in multiple organ failure and death. It is LCOS that is responsible for the majority of early postoperative deaths in this population of neonates and infants. Improved pediatric probes placed in peripheral locations using near infrared spectroscopy (NIRS) may permit continuous monitoring of venous saturations reflecting overall perfusion and oxygen balance in the tissues. Following parental or guardian consent, 30 neonates and infants scheduled to undergo surgery for congenital heart disease will be enrolled. At the end of surgery, four EQUANOX Advance 8004CB probes will be placed on the flank, lower extremities and the forehead. Continuous NIRS saturations will be monitored and stored for analysis. Point of care (POC) lactates will be obtained after admission to the intensive care unit (ICU) every 2 hours for the first 24 hours postoperatively, then once at 48 hours. The association between NIRS oxygen saturation and POC lactate values will be assessed using mixed linear models taking into account the repeated measures design. Exploratory analyses will be performed to assess whether NIRS oxygen saturation is associated with outcomes such as days in ICU, adverse events and mortality. The ability to use noninvasive, continuous monitoring for overall perfusion and cardiac output will allow better and earlier therapy for neonates and infants following cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 6, 2013
CompletedFirst Posted
Study publicly available on registry
May 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedApril 14, 2017
April 1, 2017
2.3 years
May 6, 2013
April 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Venous lactate level
48 hours post surgery
Secondary Outcomes (1)
Blood oxygen saturation level
48 hours after surgery
Study Arms (1)
Near-infrared spectroscopy (NIRS)
After cardiac surgery, all subjects will have EQUANOX Advance 8004CB sensors applied to peripheral sites (left and right calf and side of abdomen).
Interventions
The EQUANOX Advance 8004CB sensors placed in peripheral sites of neonates and infants will be used to detect peripheral perfusion and oxygen delivery.
Eligibility Criteria
pediatric cardiac surgical patients that required cardiopulmonary bypass
You may qualify if:
- pediatric patients 0-3 years of age
- scheduled to undergo cardiopulmonary bypass surgery (CPB) for repair of congenital heart defects
You may not qualify if:
- weight \< 2 kg or \> 20 kg
- greater than 3 years of age
- thrombosed femoral arteries
- prior fasciotomies
- currently on extracorporeal membrane oxygenation (ECMO)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Nonin Medical, Inccollaborator
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Oliver, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- William Oliver, MD
Study Record Dates
First Submitted
May 6, 2013
First Posted
May 8, 2013
Study Start
May 1, 2013
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
April 14, 2017
Record last verified: 2017-04